Pearl Index Study With Low Dose Combined Oral Contraceptive

NCT00220324 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
840
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer